common/saratani

Kiungo kimehifadhiwa kwenye clipboard

Chagua aina ya aina

Ukurasa 1 kutoka 20 matokeo

Peptide epitopes common to antigens of the same multigene family

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

CROSS-REFERENCE TO RELATED APPLICATION This application is a national stage of the international application PCT/FR03/00970, filed March 27, 2003, which claims benefit of the application FR 02/03888, filed Mar. 28, 2002. The present invention relates to peptides representing shared epitopes of tumor

Anti-cancer agents and androgen inhibition activity compound

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

FIELD OF THE INVENTION The present invention generally relates to the field of oncology, and particularly to the regulation of growth factors that stimulate the proliferation of cancerous cells and those that may be over-expressed, such as receptors, in cancerous cells. BACKGROUND OF THE

Chrysomycin derivative compounds and use as antitumor agents

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

TECHNICAL FIELD This invention relates to C-glycosides produced by microorganisms, and an unglycosidated product thereof. These C-glycosides have a growth-inhibiting activity, for example, against tumor cells. BACKGROUND ART A large number of compounds have been proposed as antibiotics produced by

Combine use of pterostilbene and quercetin for the production of cancer treatment medicaments

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

FIELD OF THE INVENTION The invention relates to the pharmaceutical field, concretely to the combined use of 2 active principles, pterostilbene and quercetin, in the manufacture of medicinal products that can be used for cancer treatment. STATE OF THE ART Various phenolic compounds, including

Integrated tomography--cancer treatment apparatus and method of use thereof

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

BACKGROUND OF THE INVENTION Field of the Invention This invention relates generally to treatment of solid cancers. More particularly, the invention relates to a synchrotron energy control system of a multi-axis and/or multi-field charged particle cancer therapy method and apparatus used for cancer

Targeting-enhanced anticancer nanoparticles and preparation methods of same

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

CROSS REFERENCE TO RELATED APPLICATIONS This application is a National Stage of International Application No. PCT/KR2013/004297 filed May 15, 2013, claiming priority based on Korean Patent Application No. 10-2013-0049297 filed on May 2, 2013, the contents of all of which are incorporated herein by

Targeting-enhanced anticancer nanoparticles and preparation methods of same

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

TECHNICAL FIELD This invention provides targeting-enhanced anticancer nanoparticles and preparation methods for the same. BACKGROUND ART Cancer is the most devastating disease to modern society because there are no effective treatments that do not incur side effects. Although many treatments are

Use of human prostate cell lines in cancer treatment

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

FIELD OF THE INVENTION This invention is concerned with agents for the treatment of primary, metastatic and residual cancer in mammals (including humans) by inducing the immune system of the mammal or human afflicted with cancer to mount an attack against the tumour lesion. In particular, the

Use of human prostrate cell lines in prostate cancer treatment

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

This application is a 371 of PCT/GB99/04129 filed on Dec. 9, 1999, which is hereby incorporated by reference. FIELD OF THE INVENTION This invention is concerned with agents for the treatment of primary, metastatic and residual cancer in mammals (including humans) by inducing the immune system of the

Anti-cervical cancer compound and method of use thereof

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

FIELD OF INVENTION The present invention relates to a method for treating cancer using an anti-cancer compound. More particularly, said anti-cancer compound is an anti-cervical-cancer compound. The present invention has a specific application in treating human cervical cancer. BACKGROUND OF

Synthetic peptides that cause F-actin bundling and block actin depolymerization

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

REFERENCE TO SEQUENCE LISTING The attached paper copy of the Sequence Listing for this application is identical to the Sequence Listing in computer readable form found on the accompanying computer disk, as required by 37 CFR 1.821(c), both of which are hereby incorporated by reference in their

A52688 Antibiotics and process for their production

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

SUMMARY OF THE INVENTION This invention relates to a new group of antibiotics, the A52688 complex. The A52688 complex contains at least ten factors, one of which is an analog of tuberin. The nine new A52688 factors (A, C, D, E, F, G, H, J and K) have the structures shown in formulas 1 through

Medicines manufactured from old platycodon extracts

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

TECHNICAL FIELD The present invention relates to antibiotics, anti-inflammatory agents, anti-hyperlipidemia agents, anti-diabetes agents and anticancer agents, manufactured using an old platycodon extract, based on various pharmacological effects of 20-year (or older) old platycodon produced in

Pharmaceutical composition comprising temozolomide ester

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

FIELD OF INVENTION The present invention relates to the field of medicine. More specifically, the present invention relates to Temozolomide-8-carboxylate derivatives, method for preparing it, compositions comprising them and the use of the derivatives and compositions in the manufacture of a

Semi-synthetic alanyl dilemnin analogs

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

BACKGROUND OF THE INVENTION Didemnin compounds were first reported by Rinehart et al. as isolates from the Caribbean tunicate Trididemnum solidum in 1981. These cyclic depsipeptides possess a variety of biological activities including in vitro and in vivo antiviral, antitumor, and immunosuppressive

Iliyotangulia
1
2
Ifuatayo

Jiunge na ukurasa
wetu wa facebook

Herbal & Natural Medicine

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

Inafanya kazi katika lugha 55
Uponyaji wa mitishamba unaungwa mkono na sayansi
Kutambua mimea kwa picha
Ramani ya GPS inayoshirikiana
Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
Tafuta mimea ya dawa na athari zao
Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa